Background: Atrial fibrillation (AF) and heart failure (HF) often coexist but little is known on how AF burden associates with subsequent episodes of HF.Objective: The aim of this study was to quantitatively assess the short-and long-term association of AF burden with subsequent episodes of HF events in patients with reduced ejection fraction.Methods: Patients with cardiac resynchronization therapy (CRT) devices with at least 90 days of device data were included in the study. Time-dependent Cox regression with a 7-day window was used to evaluate the association of short-and long-term AF burden with subsequent HF events. Each patient with HF was matched to two control patients without an HF event based on age, gender, year of implant and CRT defibrillation capability.Results: In our cohort with 2:1 matching (N = 549), 183 patients developed HF events and 275 (50.1%) had AF over an average follow-up of 24 ± 11 months. A 1-hour increase in short-term AF burden was associated with a 3% increased risk of HF events (HR, 1.034; 95% confidence interval [CI], 1.012-1.056; P = .01; HR for 24-hour = 2.23). In contrast, the association between long-term AF burden and subsequent HF events was not statistically significant (HR, 1.009; 95% CI, 0.992-1.026; P = .373).
Conclusion:A 24-hour increase in AF burden is associated with a more than twofold increased risk of HF events over the subsequent week while the long-term AF burden is not significantly associated with HF events. K E Y W O R D S acute decompensated heart failure, atrial fibrillation, cardiac resynchronization therapy, heart failure, heart failure hospitalization 1 | INTRODUCTION More than half of HF individuals develop AF and more than one-third of AF individuals develop HF. 1 Patients with both conditions often have a worse prognosis when compared with patients with either condition alone 2,3 Current estimates of AF prevalence are based on documented symptomatic AF events. Cardiac implantable electronic devices have been recognized as a robust way to provide continuous rhythm monitoring and detect episodes of subclinical AF. A portion of the results was presented at the 2018 AHA Scientific Sessions.